A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions
Clinical trial NCT05432583 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05432583
- Sponsor
- BioNTech SE
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-08
- Primary completion
- 2026-10-01
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.